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doi:10.1Objective: Fetal cardiac surgery might improve the prognosis of certain complex congenital heart defects that
have significant associated mortality and morbidity in utero or after birth. An important step in translating fetal
cardiac surgery is identifying potential mechanisms leading tomyocardial dysfunction after bypass. The hypoth-
esis was that fetal cardiac bypass results in myocardial dysfunction, possibly because of perturbation of calcium
cycling and contractile proteins.
Methods:Midterm sheep fetuses (n ¼ 6) underwent 30 minutes of cardiac bypass and 120 minutes of monitor-
ing after bypass. Sonomicrometric and pressure catheters inserted in the left and right ventricles measured myo-
cardial function. Cardiac contractile and calcium cycling proteins, along with calpain, were analyzed by means
of immunoblotting.
Results: Preload recruitable stroke work (slope of the regression line) was reduced at 120 minutes after bypass
(right ventricle: baseline vs 120 minutes after bypass, 38.6 6.8 vs 20.4 4.8 [P¼ .01]; left ventricle: 37 7.3
vs 20.6 3.9, respectively [P¼ .01]). Tau (in milliseconds), a measure of diastolic relaxation, was increased in
both ventricles (right ventricle: baseline vs 120 minutes after bypass, 32.7  4.5 vs 67.8  9.4 [P<.01]); left
ventricle: 26.1  3.2 vs 63.2  11.2, respectively [P ¼ .01]). Cardiac output was lower and end-diastolic pres-
sures were higher in the right ventricle, but not in the left ventricle, after bypass compared with baseline values.
Right ventricular troponin I was degraded by increased calpain activity, and protein levels of sarco(endo)plasmic
reticulum calcium ATPase were reduced in both ventricles.
Conclusions: Fetal cardiac bypass was associated with myocardial dysfunction and disruption of calcium cy-
cling and contractile proteins. Minimizing myocardial dysfunction after cardiac bypass is important for success-
ful fetal surgery to repair complex congenital heart defects. (J Thorac Cardiovasc Surg 2011;141:961-8)C
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DSupplemental material is available online.Despite impressive medical and surgical advances, certain
complex congenital heart defects (eg, hypoplastic left heart
syndrome with intact atrial septum) continue to have signif-
icant associated mortality and morbidity either in utero or
shortly after birth, often at great cost.1 This is in part due
to fetal end-organ injury that has occurred before birth be-
cause of altered intracardiac blood flow patterns.2 Fetal car-
diac surgery, alongside other evolving fetal cardiac
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The Journal of Thoracic and CaEarly studies examining fetal cardiac surgery focused on
developing tools and techniques for extracorporeal circula-
tion or fetal cardiac bypass and then overcoming the detri-
mental response of the placenta to bypass.3,4 Many of these
technical challenges have been studied and at least partially
overcome,5 but successful clinical translation has yet to be
achieved. The ability to perform intracardiac procedures de-
pends on understanding the mechanisms leading to cardiac
dysfunction and eventually developing methods to protect
the fetal myocardium.
Unlike the postnatal heart, the fetal right ventricle (RV) and
left ventricle (LV) pump in parallel, and pressure differences
between the chambers are normally minimal.6 The fetal RV
is the main pumping chamber, and output is higher compared
with that of the LV, which supplies coronary and upper body
circulation. Fetal hearts also have limited reserves to increase
cardiacoutputbecause theventricle is operatingnear the topof
its function curve.7 Increases in blood volume induce only
a small increase in fetal cardiac output,7,8 whereas increases
in heart rate and contractility are more important in
maintaining fetal cardiac output. The unique requirements
of immature circulation and myocardium require directed
protection, and understanding the myocardial dysfunction is
necessary to develop regimens for cardiac surgery.
Our research group previously demonstrated that cardio-
pulmonary bypass can result in myocardial dysfunction andrdiovascular Surgery c Volume 141, Number 4 961
Abbreviations and Acronyms
LV ¼ left ventricle
PRSW ¼ preload recruitable stroke work
RV ¼ right ventricle
SERCA2a ¼ sarco(endo)plasmic reticulum
calcium ATPase
SR ¼ sarcoplasmic reticulum
TnI ¼ troponin I
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Daltered calcium cycling in neonates.9 However, immature
cardiomyocytes differ in morphology and function from
adult and even neonatal cardiomyocytes. There are
species-specific differences in the prenatal and postnatal de-
velopment of excitation/contraction coupling and discord
regarding the maturation and importance of Ca2þ-induced
Ca2þ release and the sarcoplasmic reticulum (SR) in medi-
ating fetal contraction.10
Cardiopulmonary bypass in neonates leads to degrada-
tion of contractile proteins, possibly contributing to cardiac
dysfunction.11 Structural proteolysis of troponin I (TnI), the
inhibitory subunit of troponin, is associated with myocar-
dial stunning and reduced cardiac contractility.12 TnI is sys-
tematically degraded by the calcium-activated cysteine
protease calpain after cardiopulmonary bypass in adults
and neonates.11,13 In addition, inhibition of calpain
activation has been shown to be protective for ischemic
and hypoxic hearts.14
In the current study the hypothesis was that fetal cardiac
bypass results in postsurgical myocardial dysfunction for
the fetus. We report reduced fetal cardiac function associ-
ated with cardiac bypass procedures and present potential
mechanisms for the detected dysfunction.MATERIALS AND METHODS
Animal Model
All animals received humane care in compliancewith the ‘‘Principles of
laboratory animal care’’ formulated by the National Society for Medical
Research and the ‘‘Guide for the care and use of laboratory animals’’ pre-
pared by the Institute of Laboratory Animals (National Institutes of Health
publication no. 85-23, revised 1996). The Institutional Animal Care and
Use Committee at Cincinnati Children’s Hospital Research Foundation
also approved the protocol.
Singleton pregnant ewes from 100 to 114 days of gestation were studied;
term was approximately 148 days. Six fetuses (2.4  0.4 kg) underwent
sternotomy with 30 minutes of cardiac bypass, and 6 fetuses were killed im-
mediately after sternotomy for collection of baseline tissue samples. Surgi-
cal preparation and fetal cardiac bypass were performed as previously
described by our group.15-17 Briefly, ewes were fasted for 24 hours before
sedation with ketamine and diazepam, intubated, and maintained on 2%
isoflurane and oxygen. Ewes received buprenorphine (Buprenex; 0.3 mg
administered intramuscularly) and penicillin G. Catheters were placed in
a ewe’s femoral artery and vein for collection of blood to measure blood
gases and to deliver intravenous fluids. After midline laparotomy and
minor hysterotomy, catheters were placed in the fetal femoral artery for962 The Journal of Thoracic and Cardiovascular Surgcollecting blood samples and monitoring arterial blood pressure. Through
the same hysterotomy, an umbilical flow probe (4–6 mm; Transonic
Systems, Ithaca, NY) was placed to measure placental blood flow.
Fetal Cardiac Bypass
Using methods previously described,15-17 fetal cannulation was
performed with a 10F to 12F Bio-Medicus venous cannula (Medtronic,
Minneapolis, Minn) in the jugular vein and a 6F to 8F Bio-Medicus arterial
cannula in the carotid artery. Fetal chest sternotomy was performed to vi-
sualize cannula placement for optimal drainage and to simulate surgical
stress required in future interventional studies in the clinical application.
Hemodynamic values were continuously recorded with a PowerLab data
acquisition system (AD Instruments, Colorado Springs, Colo). Fetal car-
diac bypass was conducted with a roller pump system using normothermia,
vacuum-assisted venous drainage with a Baby-RX reservoir (Terumo,
Somerset, NJ), and a heat exchanger. The aorta was not crossclamped,
and the heart continues to be perfused. The placenta was the sole oxygen-
ator, and the blood prime for the bypass circuit was collected from a non-
maternal adult sheep. Fetal cardiac bypass lasted 30 minutes, with a target
flow rate of 200 mL $ min1 $ kg1 based on our prior studies.15-17 The
fetuses were monitored for 120 minutes after cessation of bypass. Ewes
and fetuses were killed by means of pentobarbital overdose for autopsy
measurement of fetal morphometrics, confirmation of catheter positions,
and tissue sample collection.
Fetal Cardiac Instrumentation and Measurements
Six 2-mm piezoelectric crystals (Sonometrics Corp, London, Ontario,
Canada) were glued onto 3 axes of the fetal heart, and pressure catheters
(Millar Instruments, Houston, Tex) were inserted through the myocardium
into the LVand RV, allowing real-time measurement of fetal cardiac func-
tion. Dimensional and functional analysis of fetal ventricular performance
over the course of the experiment was performed with Cardiosoft software
(Sonometrics Corp). Pressure–volume loops to measure complex contrac-
tility parameters were recorded during transient vena caval occlusion.Mea-
sured contractility parameters included the following: preload recruitable
stroke work (PRSW), the ratio of stroke work to end-diastolic volume
and a load-independent measure of systolic function; maximal elastance,
the pressure–volume relationship of end-systolic points during vena caval
occlusion and an afterload-insensitive indicator of systolic function; tau,
the isovolumic relaxation constant and a marker of diastolic function;
and end-diastolic pressure–volume relationship, an indicator of ventricular
stiffness. Stroke volume was determined by using a 2-axis ellipsoidal
model to estimate the shape of the ventricles. Tau was estimated by using
a zero asymptote exponential with a sampling interval cutoff that equaled
the end-diastolic pressure plus 5 mm Hg.
Blood-Sampling Regimen
Maternal and fetal arterial blood was collected for blood gas measure-
ment, immunoassays, and metabolite analysis immediately on gaining ar-
terial access, just before cardiac bypass, at 30 minutes of bypass, and at 30,
90, and 120 minutes after bypass. Blood gases were measured with an i-
STAT clinical analyzer, (i-STAT Corp, Windsor, NJ). Maternal and fetal
lactate values were measured with a YSI 2300-STAT analyzer (YSI
Corp, Yellow Springs, Ohio).
Western Blot Analyses
Fetal LVand RV free wall tissue samples were collected at 120 minutes
after bypass, flash-frozen, and stored at 80C until processed. Tissues
from all fetuses (n ¼ 6 per group) were homogenized in 10 mmol $ L1
3-[N-morpholino] propane sulfonic acid buffer with protease and phospha-
tase inhibitors and stored at80C until use. Western blots were performed
with 30 to 50 mg of total proteins separated on 4% to 12% acrylamide bis-
tris gradient gels (Invitrogen, Carlsbad, Calif) by means of sodiumery c April 2011
TABLE 1. Fetal myocardial contractility indices at baseline and after bypass
After bypass







RV 49.8  7.9 35.3  27.0 44.8  29.6 37.7  30.3 26.8  13.5 .77 .25
LV 47.8  18.2 32.0  25.9 37.0  16.1 35.8  12.7 39.2  12.4 .92 .57
PRSW (slope of regression)
RV 38.6  6.8 23.3  7.7* 19.7  6.3* 19.4  2.7* 20.4  4.8* .01 <.01
LV 37.0  7.3 24.5  5.4* 20.4  3.7* 25.1  5.1* 20.6  3.9* .01 .01
Tau (ms)
RV 32.7  4.5 44.2  8.4* 54.1  19.2* 56.9  6.3* 67.8  9.4* <.01 <.01
LV 26.1  3.2 48.3  17.8 55.1  24.1 67.8  22.8* 63.2  11.2* .01 .01
EDPVR (slope of regression)
RV 0.04  0.03 0.12  0.13 0.10  0.13 0.10  0.12 0.15  0.17 .77 .34
LV 0.15  0.10 0.23  0.15 0.24  0.22 0.25  0.20 0.27  0.16 .85 .29
dP/dtmax (mm Hg $ s
1)
RV 942  187 905  221 832  135 819  143 801  140 .70 .18
LV 1121  132 878  190 958  178 896  218 827  134 .14 .04
dP/dtmin (mm Hg $ s
1)
RV 854  66 681  128* 684  43* 689  78* 638  35* <.01 <.01
LV 890  75 713  132* 721  64* 704  87* 682  74* .02 <.01
SW (mL $ mm Hg1)
RV 42.8  16.1 46.2  17.8 44.5  14.8 41.3  15.5 33.2  14.1 .79 .33
LV 49.9  25.3 53.9  29.4 47.0  21.4 46.4  21.5 35.6  14.7 .83 .06
Values are means  standard deviations of 6 animals per group: in-group analyses with analysis of variance and linear trend analyses. ANOVA, Analysis of variance; RV, right
ventricle; LV, left ventricle; PRSW, preload recruitable stroke work; Tau, time constant of isovolumic relaxation; EDPVR, end-diastolic pressure–volume relationship; dP/dt, de-
rivative of the change in pressure/change in time; SW, stroke work. *P<.05 compared with baseline values by means of 1-way analysis of variance for repeated measurements.
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Ddodecylsulfate–polyacrylamide gel electrophoresis and transferred to pol-
yvinylidene fluoride membranes. Some membranes were immunoblotted
with anti–sarco(endo)plasmic reticulum calcium ATPase (SERCA2a) anti-
bodies (Abcam, Cambridge, Mass) and antibodies for total phospholamban
and phospholamban phosphorylated at serine 16 and threonine 17 (Fluores-
cience Ltd, Leeds, England). Secondary antibodies were alkaline phospha-
tase–conjugated goat anti-rabbit or anti-mouse IgG. Proteins were
visualized with a chemiluminescent detection system according to the
manufacturer’s instructions (Invitrogen). Immunoblots were also incubated
with antibodies to the housekeeping proteins a-sarcomeric actin or
glyceraldehyde-3-phosphate dehydrogenase (Abcam) for normalization
of the blots. SERCA2a and phospholamban data were presented as the ratio
of the densitometry of the target to the housekeeping proteins.
TnI Degradation
Homogenated myofibrils were concentrated from RVand LV tissue col-
lected at baseline or at 120 minutes after bypass. Five micrograms of pro-
tein from the myofibril preparation was separated by means of sodium
dodecylsulfate–polyacrylamide gel electrophoresis, as previously de-
scribed.18 Relative TnI degradation levels were measured by means of im-
munoblotting with anti-TnI antibodies (Research Diagnostics, Flanders,
NJ). Degradation of TnI was measured as the percentage in the degradation
bands of the total densitometry for TnI in each lane of the immunoblot.
Calpain Activity Assay
Calpain activity, which is responsible for the proteolysis of TnI, was
assessed in fetal RV and LV homogenates by means of fluorogenic assay
(Calbiochem, San Diego, Calif) with a SpectraMax Gemini XS spectra-
fluorometer (Molecular Devices, Sunnyvale, Calif). Cleavage of the fluo-
rescent substrate Ac-Leu-Leu-Tyr-AFC was analyzed in 96-well plates atThe Journal of Thoracic and Caan excitation of 400 nm and emission at 505 nm. Positive and negative
controls were established by the addition of calpain I and calpain inhibitor
(Z-Leu-Leu-Tyr-fluoromethyl ketone) to some samples.
Statistical Analyses
All values were expressed as means  standard deviations. The func-
tional data were analyzed by using 1-way analysis of variance for repeated
measurements with Dunnett post-hoc analyses and a post-hoc test for linear
trend with GraphPad Prism version 5.0 software for Mac (GraphPad Soft-
ware, San Diego, Calif). Western blot analyses and activity assays were
compared between treatments with analysis of variance.RESULTS
Contractility Indices
The myocardial contractility parameters are shown in
Table 1. PRSW, a load-independent index for systolic func-
tion, decreased in both ventricles when compared with
baseline values at 30, 60, 90, and 120 minutes after bypass
(P ¼ .01). In contrast, maximal elastance, an index for sys-
tolic function that is preload dependent, did not change dur-
ing the period of observation. Tau, an index of diastolic
function, increased in the RVand LV during the 120-minute
observation period (P<.01). Both ventricles showed a linear
trend for increasing Tau (P ¼ 0.01). In addition, dP/dtmin,
another index of diastolic function, was consistently lower
compared with baseline values in the RV (P< .01) and
LV (P ¼ .02) throughout the 120 minutes after bypass.rdiovascular Surgery c Volume 141, Number 4 963
TABLE 2. Fetal hemodynamic parameters at baseline and after bypass
After bypass






RV 1.1  1 0.9  0.7 0.8  0.6 0.9  0.6 0.7  0.5 .96 .48
LV 1.7  1.3 1.7  0.6 1.7  0.7 1.6  0.7 1.5  0.6 1.00 .71
CO (mL/min)
RV 199  60 130  87 115  64 111  56 71  27* .02 .01
LV 346  58 282  13 290  12 297  72 300  84 .95 .57
EDP (mm Hg)
RV 8.3  1.2 25.0  1.8* 26.3  1.9* 27.7  2.2* 30.4  3.2* <.01 <.01
LV 13.8  1.6 12.8  2.5 11.6  1.8 11.1  2.0 11.5  2.1 .41 .05
Heart rate (beats $ min1) 146  11 173  31 174  12 172  11 175  32 .52 .26
UmbQ (mL $ min1) 400  96 389  104 352  82 328  84 316  105 .63 .14
FMAP (mm Hg) 41.5  1.9 37.5  4.7 39.6  7.0 39.7  1.0 33.4  3.5 .26 .11
PVR (mm Hg $ mL1 $ min1) 0.11  0.03 0.13  0.08 0.12  0.03 0.12  0.02 0.12  0.04 .97 .96
SVR (mm Hg $ mL1 $ min1) 67.3  1.7 112.3  56.5 113.3  54.1 103  32.5 93.5  28.9 .70 .92
Values are means standard deviations of 6 animals: in-group analyses with analysis of variance and linear trend analyses. ANOVA, Analysis of variance; SV, stroke volume; RV,
right ventricle; LV, left ventricle; CO, cardiac output; EDP, end-diastolic pressure; UmbQ, placental flow; FMAP, fetal mean arterial pressure; PVR, placental vascular resistance;
SVR, systemic vascular resistance. *P<.05 compared with baseline values by means of 1-way analysis of variance for repeated measurements.
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DMyocardial function parameters are not measured during
cardiac bypass because of the dependence on extracorporeal
support.
Hemodynamic and Fetal Blood Gas Parameters
The fetal hemodynamic parameters before and after by-
pass are shown in Table 2. Hemodynamic parameters during
the bypass period were similar to those previously reported
by our research group.16 Stroke volume, heart rate, umbili-
cal blood flow, fetal arterial blood pressure, and placental
vascular resistance did not change after fetal bypass. Car-
diac output decreased in the RV after fetal cardiac bypass;
however, LV cardiac output was constant during the 120-
minute period of observation. A similar trend was observed
for end-diastolic ventricular pressure (ie, RV pressure in-
creased after bypass with steady values in the LV compared
with baseline values). Fetal PCO2 and lactate levels in-
creased whereas PO2 and pH levels decreased after bypass
(see Table E1), as previously reported by our group and
others.3,4,15-17
Contractile Protein Degradation
TnI degradation from the 29-kd intact protein to the 26-
kd degradation product was evident after fetal bypass in
the RV (Figure 1). In the RV the densitometry of the TnI
degradation band at 26 kd at baseline was 6.1%  0.7%
of the total detectable TnI and increased to 10.3% 
1.8% at 120 minutes after fetal bypass (P<.001). In the
LV no difference was detected between baseline at
6.4%  1.2% and 7.9%  2.5% at 120 minutes after by-
pass (P ¼ .41). Activity of calpain I and II, the calcium-
activated proteases that systematically degrade cardiac
TnI, increased in fetal RVand LV homogenates after cardiac964 The Journal of Thoracic and Cardiovascular Surgbypass compared with activity at baseline. Calpain activity
(in fluorescence units per milligram of protein per minute)
in the fetal LV at baseline was 461  94 and increased to
955 365 at 120 minutes after bypass (P ¼ .006). The cal-
pain activity in the RV was 393  73 at baseline and in-
creased to 775  250 at 120 minutes after fetal cardiac
bypass (P ¼ .01).
Calcium Cycling Proteins
Levels of SERCA2a protein, the SR ATPase that regu-
lates calcium reuptake from the cytosol, were reduced after
fetal bypass in both the LV and RV (Figure 2). The ratio of
SERCA2a to a-sarcomeric actin in the LV was 0.82  0.16
at baseline and 0.49  0.23 at 120 minutes after bypass
(P ¼ .02), and in the RV the ratio was 1.04  0.26 at base-
line and 0.37  0.23 after 120 minutes (P ¼ .002). In addi-
tion, phosphorylation of phospholamban at serine 16
decreased in the LV and RV after fetal bypass compared
with baseline values (Figure 3). The ratio of phosphorylated
phospholamban at serine 16 to glyceraldehyde-3-phosphate
dehydrogenase in the LV was 0.81  0.16 at baseline and
0.52  0.17 at 120 minutes after bypass (P ¼ .02), and in
the RV the ratio was 0.36  0.07 at baseline and 0.18 
0.1 after 120 minutes (P ¼ .01). There was no change in
the level of total phospholamban protein in either ventricle
compared with baseline values. Phosphorylation of
SERCA2a at threonine 17 was not detectable by means of
immunoblotting at any time point.
DISCUSSION
This is the first study that shows the hemodynamic re-
sponse of the fetal RV and LV after fetal cardiac bypass
and offers potential mechanisms for further investigationery c April 2011
FIGURE 1. Troponin I degradation in the right ventricle (RV) and left ventricle (LV) after fetal bypass. A, Representative immunoblots of troponin I (TnI) in
RVand LV tissue at baseline and 120 minutes after fetal bypass. B, TnI degraded after 120 minutes of fetal bypass expressed as a percentage of total TnI
detected in each lane (n ¼ 6 per group). *P<.05 compared with baseline controls. All lanes from the same tissues are from the same immunoblot, but
nonapplicable lanes from the center of the image have been digitally removed.
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Dof the associated cardiac dysfunction. The importance of
these findings is in understanding the response to fetal by-
pass in an acute and stressful surgical situation for future
translational studies.FIGURE 2. Sarco(endo)plasmic reticulum calciumATPase (SERCA2a) protein
Representative immunoblots of SERCA2a in RVand LV tissue at baseline and 12
as the ratio of SERCA2a to a-sarcomeric actin in each lane (n¼ 6 per group). *P
from the same immunoblot, but nonapplicable lanes from the center of the ima
The Journal of Thoracic and CaFetal Myocardial Function
The present study used a combination of sonomicrometry
and micromanometers to measure cardiac function, myo-
cardial contractility parameters, and hemodynamics of thelevels in the right ventricle (RV) and left ventricle (LV) after fetal bypass. A,
0 minutes after fetal bypass (Bypass). B, SERCA2a detected and expressed
<.05 compared with baseline controls. All lanes from the same tissues are
ge have been digitally removed.
rdiovascular Surgery c Volume 141, Number 4 965
C
FIGURE 3. Total and phosphorylated phospholamban in the right ventricle (RV) and left ventricle (LV) after fetal bypass. A, Representative immunoblots
of phospholamban (PLB) phosphorylated at serine 16 (pS16) and total PLB protein. GAPDH, Glyceraldehyde-3-phosphate dehydrogenase. B, Phosphor-
ylated PLB detected expressed as the ratio of PLB to GAPDH in each lane (n ¼ 6 per group). *P<.05 compared with baseline controls. All lanes from the
same tissues are from the same immunoblot, but nonapplicable lanes from the center of the image have been digitally removed.
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Dfetal RV and LV with fetal cardiac bypass. This methodol-
ogy is useful to assess myocardial contractility using indi-
ces such as PRSW, which is the load-independent linear
relationship between stroke work and end-diastolic volume.
Fetal systolic dysfunction was evident in the present study,
as demonstrated by lower PRSWafter bypass in both ventri-
cles. The decreased PRSW after bypass indicated a contin-
ual loss of myocardial inotropism. Aside from the decrease
in systolic parameters, we also observed diastolic dysfunc-
tion in the fetal heart after cardiac bypass, with increased
Tau and lower dP/dtmin values in both ventricles. These de-
creases in diastolic function are often indicative of calcium
cycle disruption and typically signal a loss of sufficient
myocardial relaxation between beats. Insufficient myocar-
dial relaxation leads to lower stroke volume and eventually
to lower cardiac output. The reduced fetal RVoutput trans-
lates to less umbilical blood flow and, ultimately, to placen-
tal dysfunction. The same impairment of diastolic
relaxation was reported for children undergoing cardiopul-
monary bypass for repair of congenital heart defects.19
Our in vivo findings share some similarities with previous
studies in the ex vivo fetal sheep heart, in which biventric-
ular PRSW was assessed as an index of contractility after
various methods of cardiac arrest.20 In these studies byMal-
hotra and colleagues,20 neither RV nor LV PRSW recovered
to prearrest baseline values with fibrillatory or normocalce-
mic cardioplegic arrest. Of note, the findings from these in
vitro models were generated by using single-axis sonomicr-
ometry, providing pressure–dimension relationship data as
opposed to pressure–volume relationship data. Further-
more, this in vitro model used very short prebypass and966 The Journal of Thoracic and Cardiovascular Surgpostbypass assessment periods of 15 minutes. The current
study uses 3-axis sonomicrometric measurements in vivo
to evaluate myocardial function based on biventricular pres-
sure–volume relationships for an extended 120-minute
postbypass period.
In the present study contractility was altered in both ven-
tricles after bypass, but Tau, the diastolic relaxation index,
along with cardiac output and end-diastolic pressure, was
altered earlier and more profoundly in the RV, the systemic
pump for the fetal system. Thornburg and Morton8 demon-
strated that the fetal RV, in particular, works near the top of
the Frank–Starling curves, and an additional increase in ar-
terial pressure resulted in decreased RV stroke work and
cardiac output. Zhou and associates21 determined that there
was both LVand RVmyocardial dysfunction after bypass in
a late third-trimester fetal goat model. Using echocardio-
graphic measurements, they reported that the Tei index,
which is an indication of global cardiac dysfunction, was in-
creased 1 hour after cardiac bypass.
The combined RVand LV cardiac output from the present
study was equivalent to the output reported elsewhere.6
However, the individual contribution of RVand LV cardiac
output after fetal bypass in the present study differed from
previously reported values. Of note, previous studies used
chronically instrumented animals with little fetal stress at
the time of the measurements. In contrast, the present acute
study induces a significant stress response, producing an in-
crease in serum concentrations of cortisol, b-endorphin, and
vasopressin, a potent vasoconstrictor.16 The stress response
leads to increased afterload and potentially to decreased
cardiac output. Systemic vascular resistance has a keyery c April 2011
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Drole in determining fetal cardiac output, with several studies
showing an inverse relationship between afterload and car-
diac output.8 Again, the RV cardiac output might also be
more sensitive to these changes because the circumferential
radius/wall thickness ratio is greater for the RV than the
LV.22 Therefore the wall stress in the RVat similar transmu-
ral systolic pressures is greater than in the LV and might
contribute to the lower RV cardiac output detected in the
present study. The more pronounced decrease in RV com-
pared with LV function after cardiopulmonary bypass also
occurs in children when there is increased risk of abnormal
RV diastolic dysfunction.19
We did not observe increased placental vascular resis-
tance, as previously described in the fetal sheep bypass
model,3,5 but our group has not routinely detected
significant increases in placental vascular resistance in
prior studies with this model.15,17 We have previously
reported stress-induced disruption of vasoactive mediators,
such as vasopressin and nitric oxide, after fetal cardiac by-
pass.16,17 The stable placental vascular resistance highlights
the fact that the effects of fetal cardiac bypass on
myocardial function are multifactorial and not solely due
to alterations in placental hemodynamics.
TnI Degradation
Multiple isoforms of many contractile proteins, such as
myosin heavy chain, titan, and TnI, are developmentally
regulated in the heart. This study indicated that the cardiac
TnI isoform is detectable by means of immunoblotting in
the midterm fetal sheep. The shift of TnI isoforms is linked
to a decrease in extracellular calcium sensitivity, activation
of the calcium-induced calcium release cycle, and greater
dependence on SR cycling for maintenance of intracellular
calcium homeostasis.23 Zhou and associates21 associated
increased plasma TnI levels with decreased myocardial
function in a fetal goat model. In support of these findings,
the present study detected TnI degradation in the fetal heart
by means of immunoblotting of myocardial homogenates.
TnI is systematically degraded by the calcium-activated
cysteine proteases calpain I and II after cardiopulmonary
bypass in adults13 and neonates.11 Our study indicated
that calpain was activated in the fetal myocardium after car-
diac bypass in association with degradation of troponin con-
tractile proteins and myocardial dysfunction after fetal
cardiac bypass.
Calcium Cycling
The changes in myocardial contractility might also be
due, at least in part, to alterations in calcium cycling pro-
teins. In immature myocytes the SR plays a crucial role in
regulating intracellular calcium levels because systolic con-
traction occurs with the increase in free cytosolic calcium
and diastolic relaxation occurs with the active removal of
free calcium. The movement of free calcium from theThe Journal of Thoracic and Cacytosol into the SR is controlled by cardiac SERCA2a.
Calcium reuptake by the SR can be increased by increasing
the levels of SERCA2a24 or by enhancing the affinity of
SERCA2a for calcium, a step mediated by phospholamban.
Phospholamban phosphorylated at serine 16 and threonine
17 relieves the intrinsic inhibition of SERCA2a and stimu-
lates calcium cycling through the SR.25 In this study of fetal
myocardium, lower levels of serine 16 phosphorylated
phospholamban were detected along with a decrease in
SERCA2a protein levels after fetal cardiac bypass. This
preliminary findings indicate that alterations in the calcium
reuptake proteins might be responsible, at least in part, for
the loss of myocardial contractility after bypass. Although
we did not examine additional mediators of the calcium
cycle through the SR, such as the ryanodine receptors, or in-
vestigate changes in extracellular calcium-channel regula-
tors, SERCA2a alterations are associated with cardiac
dysfunction in many forms of heart failure.24 Although
the SR response is still maturing in the fetal sheep hearts,
it appears in this study that alterations in proteins that reg-
ulate cardiac calcium cycling might be one potential mech-
anism leading to myocardial dysfunction after cardiac
bypass. This mechanism requires further investigation of
calcium movement within fetal cardiac myocytes.Summary
The development of safe, efficient fetal cardiac bypass is
essential for successful translation of fetal heart surgery for
patients with complex congenital heart disease. This will
require a greater understanding of the mechanisms that
underlie the associated myocardial dysfunction. This study,
as a first step, points toward altered calcium cycling and
contractile protein disruption as potential underlying mech-
anisms of fetal myocardial dysfunction. Further investiga-
tions are necessary to determine whether these
mechanisms are primary initiators of myocardial dysfunc-
tion. Although the focus of fetal bypass studies has previ-
ously been on correcting placental insufficiency after
bypass, protecting the fetal myocardium from cardiac by-
pass–induced injury can be equally as important for fetal
survival and subsequent development.
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TABLE E1. Fetal blood gas parameters at baseline and after bypass
After bypass
Baseline 30 min 60 min 90 min 120 min P value, ANOVA
P value,
linear trend
pH 7.28  0.04 7.26  0.10 7.21  0.10 7.17  0.14 7.13  0.14 .26 .03
PCO2 (mm Hg) 58.2  3.4 71.0  9.8 71.9  11.0 78.4  19.1 89.7  15.6* .02 .002
PO2 (mm Hg) 23.5  1.3 23.4  4.3 23.8  7.2 20.6  5.6 20.6  5.6 .76 .28
Hematocrit (%) 27.8  4.1 30.4  4.5 29.8  4.3 30.4  5.9 31.4  6.1 .87 .34
Glucose (mg $ dL1) 19.5  6.2 14.4  12.6 15.6  13.1 13.8  10.9 10.8  9.9 .83 .28
Lactate (mmol $ L1) 1.9  .4 2.8  .7 2.9  .7 3.1  .9 3.9  .9* .01 <.001
Values are means standard deviations of 6 animals. ANOVA, Analysis of variance. *P<.05 compared with baseline values by means of 1-way analysis of variance for repeated
measurements.
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